Study of SHR-7367 with other cancer drugs for solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug called SHR-7367 combined with other cancer medicines for people with solid tumors. It aims to see if the combination is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are well enough to be up and about (ECOG status 0 or 1).
- You have at least one tumor that can be measured on scans.
- Your major organs and bone marrow are working well enough.
- You have not had chemotherapy, major surgery, or another study drug in the past 4 weeks.
- You do not have active hepatitis B, C, or HIV, and any brain tumors are treated and stable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, SHR-4685, for people with solid tumors that are measurable. It aims to see if the drug is safe and how your body processes it.
This study tests a new drug called SHR-9839 given under the skin, combined with other anti-cancer treatments, for people with solid tumors. The goal is to see if it is safe and effective.
This trial tests a new drug called SHR-7782 for people with advanced cancers that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
This trial tests a new drug, HRS-7058, combined with other anti-cancer drugs for people with advanced solid tumors that cannot be surgically removed. The goal is to see if the combination can shrink tumors or slow their growth.
This trial is testing a new drug, SHR-7787, combined with other cancer treatments for people with advanced solid tumors that cannot be removed by surgery. The goal is to see if this combination can help shrink or control the cancer.
This study tests a new drug called SHR-4375 combined with other cancer treatments for people with advanced solid tumors that haven't gotten better with standard care. The goal is to see if the combination is safe and works against the cancer.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.